prostate cancer
Conditions
Interventions
intermittent docetaxel chemotherapy
Sponsors
Cancer Insutitute in Hyogo prefecture
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. histologically giagnosed as prostate cancer 2. patients must be announced as prosate cancer 3. patients have not been treated by chemotheraputic agents 4. abscent of myelosuppression, renal dysfunction and hepatic dysfunstion 5. more than 2 months of prognosis is anticipated 6. performance status of ECOG less than 2 7. written informed consent was obtained
Exclusion criteria
Exclusion criteria: 1. patients with active other malignancies at the time of enrollment 2. patients with brain or meningeal metastasis at the time of enrollment 3. patients with nerve disorder more than grade 2 in CTCAE ver4.0 (except for owing to tumor compression) 4. patients with edema more than grade 2 in CTCAE ver4.0 5. patients with pleural effusion, ascites or pericardial effusion that need medical attention 6. patients with allergy to polysorbate80 7. patients with other sever complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time to treatment failure and the duration of drug holidays quality of life | — |
Countries
Japan
Contacts
Public Contacttakaaki inoue
Cancer Insutitute in Hyogo prefecture Urology
Outcome results
None listed